Filing Flows › Comparisons › BCYC vs GYRE
Bicycle Therapeutics vs Gyre Therapeutics: BCYC and GYRE compared
Bicycle Therapeutics is the larger company: $34.1M of revenue in its latest quarter (Q3 2026) against $32.9M for Gyre Therapeutics (Q3 2026). Bicycle Therapeutics is growing faster (+190% against +0.7% a year earlier). Gyre Therapeutics is more profitable, with an operating margin of -4.6% against -39.6%.
Where the money goes: BCYC and GYRE
Bicycle Therapeutics (BCYC) · Q3 2026
Bicycle Therapeutics, Q3 2026: revenue $34.1M (+190% year over year), operating margin -39.6%, net loss $10.5M, operating cash flow −$40.3M. The chart follows the revenue to costs, profit and cash.
Gyre Therapeutics (GYRE) · Q3 2026
Gyre Therapeutics, Q3 2026: revenue $32.9M (+0.7% year over year), operating margin -4.6%, net loss $2.5M, operating cash flow −$4.0M. The chart follows the revenue to costs, profit and cash.
| Bicycle Therapeutics (BCYC) | Gyre Therapeutics (GYRE) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $34.1M | $32.9M |
| Revenue growth, Y/Y | +190% | +0.7% |
| Operating margin | -39.6% | -4.6% |
| Net earnings | −$10.5M | −$2.5M |
| Net margin | -30.8% | -7.5% |
| Operating cash flow | −$40.3M | −$4.0M |
Where the revenue comes from
Gyre Therapeutics
- Gyre Pharmaceuticals: $32.4M (98%)
- Gyre: $508K (2%)
Questions
Which is bigger, Bicycle Therapeutics or Gyre Therapeutics?
Bicycle Therapeutics is the larger company: $34.1M of revenue in its latest quarter (Q3 2026) against $32.9M for Gyre Therapeutics (Q3 2026).
Is Bicycle Therapeutics or Gyre Therapeutics growing faster?
Bicycle Therapeutics is growing faster (+190% against +0.7% a year earlier).
Which is more profitable, Bicycle Therapeutics or Gyre Therapeutics?
Gyre Therapeutics is more profitable, with an operating margin of -4.6% against -39.6%.
More: Bicycle Therapeutics earnings · how Bicycle Therapeutics makes money · Gyre Therapeutics earnings · how Gyre Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.